Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 1

1(16.7%)

Early Phase 1

1(16.7%)

6Total

N/A(4)

Phase 1(1)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03393039Not ApplicableActive Not Recruiting

Effects of Negative Affect in Individuals With Binge Eating Episodes

Role: collaborator

NCT03930342Not ApplicableCompleted

Native-Changing High-risk Alcohol Use and Increasing Contraception Effectiveness Study

Role: collaborator

NCT03454347Not ApplicableCompleted

The Efficacy of Protein Supplementation on Attenuating Muscle Atrophy Following Disuse in the Collegiate Population

Role: collaborator

NCT00959842Phase 1Completed

Effects of Lovaza on Lipoprotein Composition and Function in Mild Hypertriglyceridemia

Role: lead

NCT03302962Not ApplicableCompleted

Factors Influencing Pediatric Asthma

Role: collaborator

NCT00688961Early Phase 1Completed

Effects of Omacor and Aspirin on Platelet Function

Role: lead

All 6 trials loaded